These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26845235)

  • 21. Peptidyl-urea based inhibitors of soluble epoxide hydrolases.
    Morisseau C; Newman JW; Tsai HJ; Baecker PA; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5439-44. PubMed ID: 16908134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis.
    Gomez GA; Morisseau C; Hammock BD; Christianson DW
    Biochemistry; 2004 Apr; 43(16):4716-23. PubMed ID: 15096040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Farrow NA; Kukulka A; De Lombaert S
    Bioorg Med Chem Lett; 2010 Jan; 20(2):571-5. PubMed ID: 19969453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
    Sun YN; Kim JH; Li W; Jo AR; Yan XT; Yang SY; Kim YH
    Bioorg Med Chem; 2015 Oct; 23(20):6659-65. PubMed ID: 26372074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing ligand-binding modes and binding mechanisms of benzoxazole-based amide inhibitors with soluble epoxide hydrolase by molecular docking and molecular dynamics simulation.
    Chen H; Zhang Y; Li L; Han JG
    J Phys Chem B; 2012 Aug; 116(34):10219-33. PubMed ID: 22857012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High-throughput screening of human soluble epoxide hydrolase inhibitors].
    Wang SB; Guo J; Yu XM; Du GH
    Yao Xue Xue Bao; 2010 Nov; 45(11):1367-72. PubMed ID: 21361036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of vascular smooth muscle cell proliferation by 1-cyclohexyl-3-dodecyl urea is independent of soluble epoxide hydrolase inhibition.
    Davis BB; Morisseau C; Newman JW; Pedersen TL; Hammock BD; Weiss RH
    J Pharmacol Exp Ther; 2006 Feb; 316(2):815-21. PubMed ID: 16221742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase.
    Eldrup AB; Soleymanzadeh F; Taylor SJ; Muegge I; Farrow NA; Joseph D; McKellop K; Man CC; Kukulka A; De Lombaert S
    J Med Chem; 2009 Oct; 52(19):5880-95. PubMed ID: 19746975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory Activity of Quercetin 3-
    Cho IS; Kim JH; Lin Y; Su XD; Kang JS; Yang SY; Kim YH
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32972033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.
    Kato Y; Fuchi N; Saburi H; Nishimura Y; Watanabe A; Yagi M; Nakadera Y; Higashi E; Yamada M; Aoki T
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5975-9. PubMed ID: 24035338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase.
    Anandan SK; Gless RD
    Bioorg Med Chem Lett; 2010 May; 20(9):2740-4. PubMed ID: 20363133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a high-throughput screen for soluble epoxide hydrolase inhibition.
    Wolf NM; Morisseau C; Jones PD; Hock B; Hammock BD
    Anal Biochem; 2006 Aug; 355(1):71-80. PubMed ID: 16729954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory Activity of Flavonoids, Chrysoeriol and Luteolin-7-
    Kim JH; Jin CH
    Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31991570
    [No Abstract]   [Full Text] [Related]  

  • 34. Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
    Takai K; Nakajima T; Takanashi Y; Sone T; Nariai T; Chiyo N; Nakatani S; Ishikawa C; Yamaguchi N; Fujita K; Yamada K
    Bioorg Med Chem; 2014 Mar; 22(5):1548-57. PubMed ID: 24530032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase.
    Tran KL; Aronov PA; Tanaka H; Newman JW; Hammock BD; Morisseau C
    Biochemistry; 2005 Sep; 44(36):12179-87. PubMed ID: 16142916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble epoxide hydrolase inhibitory activity of components from Leonurus japonicus.
    Leem HH; Lee GY; Lee JS; Lee H; Kim JH; Kim YH
    Int J Biol Macromol; 2017 Oct; 103():451-457. PubMed ID: 28501602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Random Forest Model to Predict the Activity of a Large Set of Soluble Epoxide Hydrolase Inhibitors Solely Based on a Set of Simple Fragmental Descriptors.
    Shamsara J
    Comb Chem High Throughput Screen; 2019; 22(8):555-569. PubMed ID: 31622216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble epoxide hydrolase inhibitory activity of phenolic components from the rhizomes and roots of Gentiana scabra.
    Li W; Kim JH; Zhou W; Shim SH; Ma JY; Kim YH
    Biosci Biotechnol Biochem; 2015; 79(6):907-11. PubMed ID: 25588498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
    Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
    ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and Biological Evaluation of Soluble Epoxide Hydrolase Inhibitors: Assessing the Role of Hydrophobicity in the Pharmacophore-Guided Search of Novel Hits.
    Vázquez J; Ginex T; Herrero A; Morisseau C; Hammock BD; Luque FJ
    J Chem Inf Model; 2023 May; 63(10):3209-3225. PubMed ID: 37141492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.